Disability and emotional symptoms in women with lipedema: A comparison with overweight/obese women.

IF 2.1 4区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Advances in Clinical and Experimental Medicine Pub Date : 2024-12-01 DOI:10.17219/acem/181146

Angelika Chachaj, Małgorzata Jeziorek, Ilona Dudka, Monika Sowicz, Agnieszka Adaszyńska, Aleksander Truszyński, Justyna Putek, Edwin Kuźnik, Krzysztof Małyszczak, Krzysztof Kujawa, Andrzej Szuba

{"title":"Disability and emotional symptoms in women with lipedema: A comparison with overweight/obese women.","authors":"Angelika Chachaj, Małgorzata Jeziorek, Ilona Dudka, Monika Sowicz, Agnieszka Adaszyńska, Aleksander Truszyński, Justyna Putek, Edwin Kuźnik, Krzysztof Małyszczak, Krzysztof Kujawa, Andrzej Szuba","doi":"10.17219/acem/181146","DOIUrl":null,"url":null,"abstract":"Background: Lipedema is characterized by the painful abnormal deposition of adipose tissue in the lower limbs and is often misdiagnosed as obesity. Considering the numerous bothersome physical symptoms of lipedema, women with lipedema may have greater disability and emotional problems than women with lifestyle-induced obesity.Objectives: Our study aims to assess disability, anxiety and depression symptoms in women with lipedema compared to women with overweight/obesity.Material and methods: Women with lipedema (n = 45, with a mean age of 41 years) and women who are overweight/obese (n = 43, with a mean age of 44.95 years) were asked to complete the following questionnaires: The World Health Organization Disability Assessment Schedule (WHO-DAS II), Beck's Depression Inventory - II (BDI-II), and The Hospital Anxiety and Depression Scale (HADS).Results: Despite the higher BMI in the overweight/obesity group, the group with lipedema was more disabled in numerous domains of the WHO-DAS II questionnaire, including Life activities - domestic, work and school responsibilities and Participation in society When the influence of BMI was adjusted, a difference in the domain of Mobility was also present. The study groups did not differ in anxiety and depression symptoms.Conclusions: We showed that behavioral impairment was the main factor affecting functioning in women with lipedema. Emotional symptoms did not differentiate the study groups. Leg volumes and adipose tissue pain intensity were associated with greater disability in women with lipedema, and should be considered in managing women with this condition and in future research estimating the effectiveness of lipedema treatment.","PeriodicalId":7306,"journal":{"name":"Advances in Clinical and Experimental Medicine","volume":" ","pages":"1367-1377"},"PeriodicalIF":2.1000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical and Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.17219/acem/181146","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Lipedema is characterized by the painful abnormal deposition of adipose tissue in the lower limbs and is often misdiagnosed as obesity. Considering the numerous bothersome physical symptoms of lipedema, women with lipedema may have greater disability and emotional problems than women with lifestyle-induced obesity.

Objectives: Our study aims to assess disability, anxiety and depression symptoms in women with lipedema compared to women with overweight/obesity.

Material and methods: Women with lipedema (n = 45, with a mean age of 41 years) and women who are overweight/obese (n = 43, with a mean age of 44.95 years) were asked to complete the following questionnaires: The World Health Organization Disability Assessment Schedule (WHO-DAS II), Beck's Depression Inventory - II (BDI-II), and The Hospital Anxiety and Depression Scale (HADS).

Results: Despite the higher BMI in the overweight/obesity group, the group with lipedema was more disabled in numerous domains of the WHO-DAS II questionnaire, including Life activities - domestic, work and school responsibilities and Participation in society When the influence of BMI was adjusted, a difference in the domain of Mobility was also present. The study groups did not differ in anxiety and depression symptoms.

Conclusions: We showed that behavioral impairment was the main factor affecting functioning in women with lipedema. Emotional symptoms did not differentiate the study groups. Leg volumes and adipose tissue pain intensity were associated with greater disability in women with lipedema, and should be considered in managing women with this condition and in future research estimating the effectiveness of lipedema treatment.

查看原文本刊更多论文

患有脂肪性水肿的妇女的残疾和情绪症状：与超重/肥胖妇女的比较。

背景：脂肪性水肿的特点是脂肪组织异常沉积在下肢，令人疼痛，常被误诊为肥胖症。考虑到脂肪性水肿有许多令人烦恼的身体症状，与生活方式引起的肥胖相比，患有脂肪性水肿的女性可能会有更大的残疾和情绪问题：我们的研究旨在评估与超重/肥胖女性相比，患有脂肪性水肿的女性的残疾、焦虑和抑郁症状：患有脂肪性水肿的女性（45 人，平均年龄 41 岁）和超重/肥胖的女性（43 人，平均年龄 44.95 岁）被要求填写以下问卷：世界卫生组织残疾评估表（WHO-DAS II）、贝克抑郁量表-II（BDI-II）和医院焦虑抑郁量表（HADS）：尽管超重/肥胖组的体重指数（BMI）较高，但脂肪性水肿组在 WHO-DAS II 问卷的多个领域（包括生活活动--家务、工作和学校责任以及社会参与）中的残疾程度更高。研究组在焦虑和抑郁症状方面没有差异：我们的研究表明，行为障碍是影响脂肪性水肿女性功能的主要因素。结论：我们的研究结果表明，行为障碍是影响脂肪性水肿女性患者功能的主要因素，情绪症状在研究组中并无差异。腿部体积和脂肪组织疼痛强度与患有脂肪性水肿的女性的残疾程度有关，在管理患有脂肪性水肿的女性以及在未来评估脂肪性水肿治疗效果的研究中应加以考虑。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Clinical and Experimental Medicine MEDICINE, RESEARCH & EXPERIMENTAL-

CiteScore

3.70

自引率

4.80%

发文量

153

审稿时长

6-12 weeks

期刊介绍： Advances in Clinical and Experimental Medicine has been published by the Wroclaw Medical University since 1992. Establishing the medical journal was the idea of Prof. Bogumił Halawa, Chair of the Department of Cardiology, and was fully supported by the Rector of Wroclaw Medical University, Prof. Zbigniew Knapik. Prof. Halawa was also the first editor-in-chief, between 1992-1997. The journal, then entitled "Postępy Medycyny Klinicznej i Doświadczalnej", appeared quarterly. Prof. Leszek Paradowski was editor-in-chief from 1997-1999. In 1998 he initiated alterations in the profile and cover design of the journal which were accepted by the Editorial Board. The title was changed to Advances in Clinical and Experimental Medicine. Articles in English were welcomed. A number of outstanding representatives of medical science from Poland and abroad were invited to participate in the newly established International Editorial Staff. Prof. Antonina Harłozińska-Szmyrka was editor-in-chief in years 2000-2005, in years 2006-2007 once again prof. Leszek Paradowski and prof. Maria Podolak-Dawidziak was editor-in-chief in years 2008-2016. Since 2017 the editor-in chief is prof. Maciej Bagłaj. Since July 2005, original papers have been published only in English. Case reports are no longer accepted. The manuscripts are reviewed by two independent reviewers and a statistical reviewer, and English texts are proofread by a native speaker. The journal has been indexed in several databases: Scopus, Ulrich’sTM International Periodicals Directory, Index Copernicus and since 2007 in Thomson Reuters databases: Science Citation Index Expanded i Journal Citation Reports/Science Edition. In 2010 the journal obtained Impact Factor which is now 1.179 pts. Articles published in the journal are worth 15 points among Polish journals according to the Polish Committee for Scientific Research and 169.43 points according to the Index Copernicus. Since November 7, 2012, Advances in Clinical and Experimental Medicine has been indexed and included in National Library of Medicine’s MEDLINE database. English abstracts printed in the journal are included and searchable using PubMed http://www.ncbi.nlm.nih.gov/pubmed.